期刊文献+

IL-8调节卵巢癌细胞VEGF表达、体外黏附与侵袭特性的机制研究 被引量:6

The mechanisms of IL-8 in regulating VEGF expression level,cell adhesion and invasion of ovarian cancer cells in vitro
下载PDF
导出
摘要 目的探讨IL-8对卵巢癌细胞VEGF表达水平、体外黏附和侵袭特性的影响及相关分子机制。方法在原工作基础上,利用前期构建的过表达IL-8的人卵巢癌A2780细胞株和抑制表达IL-8的人卵巢癌SKOV3细胞株,分别应用半定量RT-PCR法、Western blot技术、细胞体外黏附实验、Transwell小室体外侵袭实验及明胶酶谱法等观察IL-8对卵巢癌细胞VEGF表达、黏附和侵袭特性的影响,并对其作用机制和可能的信号通路进行研究。结果与对照组相比,过表达IL-8可增强卵巢癌细胞VEGF的基因转录和蛋白表达水平,促进细胞的体外黏附和侵袭能力(P<0.001);抑制IL-8表达,细胞的VEGF表达水平和黏附、侵袭能力均减弱。进一步研究发现,IL-8的促细胞黏附和侵袭活性,与激活PI3K/Akt和Raf/MEK/ERK信号通路、增强MMP-2和MMP-9的活性和表达水平密切相关。结论 IL-8可促进卵巢癌细胞VEGF表达,增强细胞的黏附侵袭能力;IL-8及其相关信号分子有望成为抑制肿瘤转移、延缓病程进展的新靶点。 This study designed to explore the mechanisms of interleukin-8 (IL-8) in regulating VEGF expression, cell adhesion and invasion of ovarian cancer (OVCA) cells and its related signal pathways. Based on our previous studies, overexpression of IL-8 in non-IL-8-expressing A2780 cells (by transfecting with plasmid encoding for sense IL-8) increases VEGF level, cell adhesion and invasion in vitro, while depletion of IL-8 in IL- 8-overexpressing SKOV3 cells (by transfecting with plasmid encoding for antisense IL-8) decreases the above effects. Further investigation indicated that IL-8-stimulated cell adhesion correlated with aetivation of PI3K/Akt and Raf/MEK/ERK, whereas IL-8-enhanced OVCA cell invasive correlated with increased MMP-2 and MMP-9 activity and expression. These data suggest that IL-8 secreted by OVCA cells can promote angiogenic potential, cell adhesion and invasion. Therefore, modulation of IL-8 expression or its related signaling pathway may be a promising strategy for controlling the progression and metastasis of OVCA.
出处 《免疫学杂志》 CAS CSCD 北大核心 2013年第6期467-473,479,共8页 Immunological Journal
基金 国家自然科学基金项目(81273520) 天津市自然科学基金重点项目(12JCZDJC26300) 武警后勤学院科学技术研究项目(WHZ201202,WYM201105,WYQ201105)
关键词 IL-8 卵巢癌细胞 VEGF 细胞黏附 细胞侵袭 Interleukin-8 Ovarian cancer cells VEGF Cell adhesion Cell invasion
  • 相关文献

参考文献27

  • 1Agarwal R, Kaye SB. Ovarian cancer: strategies for overcoming resistance to chemotherapy[J]. Nat Rev Cancer, 2003, 3(7): 502-516.
  • 2Kassim SK, E1 Salahy EM, Fayed ST, et al. Vascular endothelial growth factor and interleukin-8 are associated with poor prognosis in epithelial ovarian cancer patients[J]. Clin Biochem, 2004, 37(5): 363-369.
  • 3Giuntoli RL 2nd, Webb TJ, Zoso A, et al. Ovarian cancer- associated ascites demonstrates altered immune environment: implications for antitumor immunity [J]. Anticancer Res, 2009, 29(8): 2875-2884.
  • 4Nowak M, Glowaeka E, Szpakowski M, et al. Proinflammatory and immunosuppressive serum, ascites and cyst fluid eytokines in patients with early and advanced ovarian cancer and benign ovarian tumors [J]. Neuro Endoerinol Lett, 2010, 31(3): 375-383.
  • 5Merritt WM, Lin YG, Spannuth WA, et al. Effect of interleukin-8 gene silencing with liposome-encapsulated small interfering RNA on ovarian cancer cell growth[J]. J Natl Cancer Inst, 2008, 100(5): 359-372.
  • 6Uslu R, Sanli UA, Dikmen Y, et al. Predictive value of serum interleukin-8 levels in ovarian cancer patients treated with paclitaxel-containing regimens [J]. Int J Gynecol Cancer, 2005, 15(2): 240-245.
  • 7Wang Y, Qu Y, Niu XL, et al. Autocrine production of interleukin-8 confers cisplatin and paclitaxel resistance in ovarian cancer cells[J]. Cytokine, 2011, 56(2): 365-375.
  • 8牛秀珑,陈晓,张晓雷,毛立群,王越.内源性IL-8诱导卵巢癌细胞对顺铂与紫杉醇产生耐药的机制研究[J].免疫学杂志,2012,28(8):645-650. 被引量:7
  • 9Xie K. Interleukin-8 and human cancer biology [J].Cytokine Growth Factor Rev, 2001,12(4): 375-391.
  • 10Tanaka T, Bai Z, Srinoulprasert Y, et al. Chemokines in tumor progression and metastasis[J]. Cancer Sci, 2005, 96(6): 317-322.

二级参考文献16

  • 1王越,牛秀珑,郭小芹,吴健,朱雅琴,毛立群,屈野,李覃.卵巢癌细胞IL-6、IL-8分泌与其化疗敏感性及耐药相关基因和凋亡抑制基因表达关系的初步探讨[J].免疫学杂志,2009(4):436-441. 被引量:11
  • 2Penson RT, Kronish K, Duan Z, et al. Cytokines IL-1beta, IL-2, IL-6, IL-8, MCP-1, GM-CSF and TNFalpha in patients with epithelial ovarian cancer and their relationship to treatment with paclitaxel[J]. Int J Gynecol Cancer, 2000, 10(1): 33-41.
  • 3Merritt WM, Lin YG, Spannuth WA. Ettect of interleukin-8 gene silencing with liposome-encapsulated small interfering RNA on ovarian cancer cell growth[J]. J Natl Cancer Inst, 2008, 100(5): 359-372.
  • 4Toutirais O, Chartier P, Dubois D, et al. Constitutive expression of TGF-beta, interleukin-6 and interleukin-8 by tumor cells as a major component of immune escape in human ovarian carcinoma[J]. Eur Cytokine Netw, 2003, 14(4): 246-255.
  • 5Wang Y, Yang J, Gao Y, et al. Reciprocal regulation of 5alpha-dihydrotestosterone, interleukin-6 and interleukin- 8 during proliferation of epithelial ovarian carcinoma [J]. Cancer Biol Ther, 2007, 6(6): 864-871.
  • 6Duan Z, Feller AJ, Penson RT, et al. Discovery of differentially expressed genes associated with paclitaxel resistance using cDNA array technology: analysis of interleukin (IL) 6, IL-8, and monocyte ehemotactic protein 1 in the paclitaxel-resistant phenotype[J]. Clin Cancer Res, 1999, 5(11): 3445-3453.
  • 7Kamazawa S, Kigawa J, Kanamori Y, et al. Multidrug resistance gene-1 is a useful predictor of Paclitaxel-based chemotherapy for patients with ovarian cancer [J]. Gynecol Oncol, 2002, 86(2): 171-176.
  • 8Naniwa J, Kigawa J, Kanamori Y, et al. Genetic diagnosis for chemosensitivity with drug-resistance genes in epithelial ovarian cancer[J]. Int J Gynecol Cancer, 2007, 17(1): 76-82.
  • 9Yamatsuji T, Matsuoka J, Nishiyama M, et al. Molecular mechanism of chemoresistance to cisplatin in ovarian cancer cell lines[J]. Int J Mol Med, 2004, 13(6): 865-868.
  • 10Williams J, Lucas PC, Griffith KA, et al. Expression of Bcl-xL in ovarian carcinoma is associated with chemoresistance and recurrent disease[J]. Gynecol Oncol, 2005, 96(2):. 287-295.

共引文献6

同被引文献123

引证文献6

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部